Navigation Links
Kosan Announces Fourth Quarter and Full Year 2007 Financial Results and 2008 Outlook
Date:2/28/2008

trials; manufacturing; regulatory approval requirements and process; the effort and expense necessary for further development of Kosan's product candidates, including the costs of bortezomib; intellectual property matters, including Kosan's ability to obtain valid and enforceable patents covering its product candidates; Kosan's dependence on its collaboration with Pfizer for development of its motilin agonist product candidate; Kosan's need for additional financing and Kosan's strategy to enter into partnering or licensing arrangements. These and other risk factors are discussed under "Risk Factors" in Kosan's Quarterly Report on Form 10-Q for the quarter ended September 30, 2007 and other periodic filings with the SEC. Kosan expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein.

Velcade(R) (bortezomib) is a registered trademark of Millennium Pharmaceuticals, Inc.
Herceptin(R) (trastuzumab) is a registered trademark of Genentech, Inc.

Selected Financial Information

Condensed Statements of Operations

(in thousands, except per share amounts)

Three Months Ended Year Ended

December 31, December 31,

2007 2006 2007 2006

(unaudited) (unaudited)

Total revenues $5,636 $5,710 $22,707 $13,506

Operating expenses:

Research and development 13,902 8,817 47,283 37,179

General and administrative 2,108 2,090 8,162 7,823

Total operating expenses 16,010 10,907 55,445 45,002

Loss from operations (10,374) (5,197) (32,738) (31,496)

Other income, net 893 638 4,080 2,027

Net loss
'/>"/>

SOURCE Kosan Biosciences Incorporated
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. Kosan Announces February 28, 2008 Conference Call and Webcast
2. Kosans Hsp90 Inhibitor, Tanespimycin, Shows 55% Clinical Benefit in Patients With Trastuzumab-Refractory Metastatic Breast Cancer
3. Kosan Announces Third Quarter 2007 Financial Results
4. Kosan to Reacquire Epothilone Program From Roche
5. Kosan Biosciences to Host Research & Development Day on October 31, 2007
6. Kosan Biosciences to Present at the Biotechnology Industry Organization Investor Forum
7. Kosan Biosciences to Present at the 2007 UBS Global Life Sciences Conference
8. Kosan Biosciences to Present at the Bear Stearns 20th Annual Healthcare Conference
9. Wyeth Announces Executive Change in Finance Organization
10. Insmed Announces Listing Transfer from Nasdaq Global Market to Nasdaq Capital Market
11. Pharmacopeia Announces Management Team Changes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... Davis, California (PRWEB) January 22, 2015 ... of Accelerator Mass Spectrometry (AMS) services to the pharmaceutical ... PhD has joined the company in the position of ... 30 years of broad and valuable experience in drug ...
(Date:1/22/2015)... January 21, 2015 Cambridge Semantics, the leading ... today announced that 2014 was a record-breaking year across the ... of the Anzo Smart Data Platform and our Smart Data ... insights from diverse data which led to record growth for ...
(Date:1/22/2015)... 2015 zFlo Motion , a US ... an exciting product from a new partner. STT-Systems ... the past 15 years, with offerings in the optical-motion capture, ... IMU system (inertial measurement unit), iSen, is opening eyes around ...
(Date:1/22/2015)... NEW BRUNSWICK , Nueva Jersey , 22 ... Award for Biomedical Research abre hoy su llamada ... las personas cuya investigación científica ha hecho, o tiene ... de la salud humana. Las nominaciones se aceptarán hasta ...
Breaking Biology Technology:Eckert & Ziegler Vitalea Science appoints Mark Seymour, PhD as Director of Science & Technology 2Eckert & Ziegler Vitalea Science appoints Mark Seymour, PhD as Director of Science & Technology 3Cambridge Semantics Announces Record Results for 2014 23D Motion Capture Just Got Easy 2El Dr. Paul Janssen Award for Biomedical Research emite su llamada a los nominados para 2015 2El Dr. Paul Janssen Award for Biomedical Research emite su llamada a los nominados para 2015 3El Dr. Paul Janssen Award for Biomedical Research emite su llamada a los nominados para 2015 4
... 2011 Advanstar|CBI recently announced the full agenda for ... co-sponsored by 3d Communications. The Forum takes place February ... for FDA Advisory Committees, speaker faculty includes leading experts ... Development Center and many more. Leveraging ...
... Engineering researchers at the University of Toronto have ... on plastic. This result enables a flexible form factor, ... OLED manufacturing, which currently relies on rigid glass. ... issue of Nature Photonics . OLEDs provide ...
... Neurocrine Biosciences, Inc. (NASDAQ: NBIX ) today announced its ... For the third quarter of 2011, the Company reported net ... compared to net income of $3.3 million, or $0.06 per fully ... nine months ended September 30, 2011, the Company reported a net ...
Cached Biology Technology:CBI Announces 3rd Effective Preparation for FDA Advisory Committees 2University of Toronto researchers create world's most efficient flexible OLED on plastic 2Neurocrine Biosciences Reports Third Quarter 2011 Results 2Neurocrine Biosciences Reports Third Quarter 2011 Results 3Neurocrine Biosciences Reports Third Quarter 2011 Results 4Neurocrine Biosciences Reports Third Quarter 2011 Results 5Neurocrine Biosciences Reports Third Quarter 2011 Results 6Neurocrine Biosciences Reports Third Quarter 2011 Results 7Neurocrine Biosciences Reports Third Quarter 2011 Results 8
(Date:1/22/2015)... Inc. , a market leader of iris-based identity authentication solutions, ... the new role of Senior Vice President of Mobile and ... platforms and wearable solutions for EyeLock,s technologies. Gerber brings more ... industry to his role at EyeLock, with expertise in human ...
(Date:12/22/2014)... DENVER , Dec. 22, 2014  The 2014 Holiday ... industry as Acuity Market Intelligence reports that the long ... Acuity forecasts that intensifying demand for smart phones, tablets, ... a global market of 2.5 billion users with nearly ...
(Date:12/17/2014)... and Markets ( http://www.researchandmarkets.com/research/s6qzt5/samsung_galaxy_s5 ) has announced ... Home Button Synaptics Fingerprint Sensor Technology Analysis" report ... Based on a totally different sensing ... first time a fingerprint sensor in its product. ...
Breaking Biology News(10 mins):EyeLock Names Steve Gerber as Senior Vice President of Mobile and Wearables 2First Season of Holiday Shopping with Mobile Biometric Payments Wraps Up With a Present for Biometrics Industry: A Rosy Forecast for More Than 2 Billion Users of 4.8 Billion Mobile Biometric Devices by 2020 2Samsung Galaxy S5 - Home Button Synaptics Fingerprint Sensor Technology Analysis 2
... bacterium behind one of mankind,s deadliest scourges, tuberculosis, is ... Standards and Technology (NIST) and the Department of Energy,s ... decades-old question of what controls the switching on and ... functions. In a Journal of Biological Chemistry ...
... Complete Genomics, Inc. released proof-of-concept (PoC) data for ... yesterday evening. The analysis results were reviewed by Dr. ... his presentation at the annual Advances in Genome Biology ... Beach Resort, Marco Island, Fla. Complete Genomics successfully ...
... Richard B. Sher, PhD, a professor of history at ... National Endowment for the Humanities (NEH) Fellowship to edit ... eighteenth-century Scottish writer. Boswell was best known for his ... on the thought and culture of 18th century Scotland. ...
Cached Biology News:Long-sought protein structure may help reveal how 'gene switch' works 2Long-sought protein structure may help reveal how 'gene switch' works 3Complete Genomics releases proof-of-concept data for its sequencing technology for the first time 2Complete Genomics releases proof-of-concept data for its sequencing technology for the first time 3
Mouse monoclonal antibody to FMN2 - formin 2...
...
Anti-Human Complement Component C4c, IgY fraction (Polyclonal) (chicken IgY)...
... (KLF15) KLF15 is a Cys2-His2 zinc ... in the liver, kidneys, heart, and skeletal ... Polyclonal antibody produced in rabbits immunized with ... of human KLF15 with an internal ID ...
Biology Products: